Technology And Equipment Tenders

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Bimekizumab, Atc L04ac21 (Obo) for the Period October 1St, 2024 - September 30Th, 2026

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Dapagliflozin, Atc A10bk01 (Obo) for the Period October 1St, 2024 - September 30Th, 2026

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Faricimab, Atc S01la09 (Obo) for the Period October 1St, 2024 - September 30Th, 2026

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Allergen Extract from Exclusively Timothy Grass Pollen (Excl. Sut), Atc V01aa02 F. D. Z. 01.10.24-30.09.26

Medicine Discount Contracts in Accordance with Section 130A Paragraph 8 Sgb V as Part of Open House Procedures

Open House Drug Discount Agreements Timolol and Latanoprost, Atc S01ed61

Open House Drug Discount Agreements Lisdexamfetamine, Atc N06ba12

Open House Drug Discount Agreements Miglustat, Atc A16ax06

Open House Drug Discount Agreements Raltegravir, Atc J05aj01

Open House Drug Discount Contracts Treprostinil, Atc B01ac21